SCOTTSDALE, Ariz. – Men with hypogonadism who developed deep vein thromboses (DVTs) weren't more likely to have recently been on testosterone-replacement therapy (TRT), a new study found, challenging ...

Men treated with testosterone replacement therapy (TRT) for hypogonadism didn't have an increase in adverse prostate events, the TRAVERSE trial found. Over a mean follow-up of 33 months, those who ...

Testosterone replacement therapy (TRT) in men with secondary hypogonadism due to nonfunctioning pituitary adenomas or prolactinomas is associated with a significantly lower risk of major adverse ...

This article was reviewed by Felix Gussone, MD. Key Takeaways: Testosterone does more than drive puberty. It influences drive ...

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. RJK Jr. has explored a few controversial ideas, particularly in ...

Hims announced that TRT therapy would be coming to its telehealth platform this year. But a grey market still thrives as recreational use supersedes medical needs.